124 related articles for article (PubMed ID: 28189974)
1. Effect of inhaled and systemic glucocorticoid treatment on CD4
Zuśka-Prot M; Maślanka T
Int Immunopharmacol; 2017 Apr; 45():98-109. PubMed ID: 28189974
[TBL] [Abstract][Full Text] [Related]
2. Inhaled glucocorticoid treatment prevents the response of CD8
Zuśka-Prot M; Maślanka T
Int Immunopharmacol; 2017 Dec; 53():63-72. PubMed ID: 29040944
[TBL] [Abstract][Full Text] [Related]
3. IκB kinase β inhibitor, IMD-0354, prevents allergic asthma in a mouse model through inhibition of CD4(+) effector T cell responses in the lung-draining mediastinal lymph nodes.
Maślanka T; Otrocka-Domagała I; Zuśka-Prot M; Mikiewicz M; Przybysz J; Jasiecka A; Jaroszewski JJ
Eur J Pharmacol; 2016 Mar; 775():78-85. PubMed ID: 26868187
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, in a mouse allergic asthma model is not associated with the recruitment or generation of Foxp3-expressing CD4
Maślanka T; Otrocka-Domagała I; Zuśka-Prot M; Gesek M
Eur J Pharmacol; 2019 Apr; 848():30-38. PubMed ID: 30710547
[TBL] [Abstract][Full Text] [Related]
5. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model.
Wei Y; Luo QL; Sun J; Chen MX; Liu F; Dong JC
J Ethnopharmacol; 2015 Apr; 164():368-77. PubMed ID: 25625352
[TBL] [Abstract][Full Text] [Related]
6. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
[TBL] [Abstract][Full Text] [Related]
7. Induction of tolerogenic lung CD4+ T cells by local treatment with a pSTAT-3 and pSTAT-5 inhibitor ameliorated experimental allergic asthma.
Hausding M; Tepe M; Ubel C; Lehr HA; Röhrig B; Höhn Y; Pautz A; Eigenbrod T; Anke T; Kleinert H; Erkel G; Finotto S
Int Immunol; 2011 Jan; 23(1):1-15. PubMed ID: 21135031
[TBL] [Abstract][Full Text] [Related]
8. [Effect of glucocorticoid on CD4+CD25+ T regulatory cells in asthmatic mice].
Li M; Song L; Zhang JB; Fang J; Li L
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):527-30. PubMed ID: 18706179
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids decrease Treg cell numbers in lungs of allergic mice.
Olsen PC; Kitoko JZ; Ferreira TP; de-Azevedo CT; Arantes AC; Martins ΜA
Eur J Pharmacol; 2015 Jan; 747():52-8. PubMed ID: 25499819
[TBL] [Abstract][Full Text] [Related]
10. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
Sun JB; Czerkinsky C; Holmgren J
Scand J Immunol; 2007; 66(2-3):278-86. PubMed ID: 17635805
[TBL] [Abstract][Full Text] [Related]
11. Blockade of RANKL/RANK and NF-ĸB signalling pathways as novel therapeutic strategies for allergic asthma: A comparative study in a mouse model of allergic airway inflammation.
Gregorczyk I; Maślanka T
Eur J Pharmacol; 2020 Jul; 879():173129. PubMed ID: 32339516
[TBL] [Abstract][Full Text] [Related]
12. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.
Finotto S; Eigenbrod T; Karwot R; Boross I; Doganci A; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Rose-John S; Galle PR; Neurath MF
Int Immunol; 2007 Jun; 19(6):685-93. PubMed ID: 17496315
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticosteroids administration is associated with increased regulatory T cells in equine asthmatic lungs.
Boivin R; Vargas A; Cano P; Lavoie JP
Vet Immunol Immunopathol; 2018 Jul; 201():67-71. PubMed ID: 29914685
[TBL] [Abstract][Full Text] [Related]
14. LAT alleviates Th2/Treg imbalance in an OVA-induced allergic asthma mouse model through LAT-PLC-γ1 interaction.
Chen X; Li XM; Gu W; Wang D; Chen Y; Guo XJ
Int Immunopharmacol; 2017 Mar; 44():9-15. PubMed ID: 28063403
[TBL] [Abstract][Full Text] [Related]
15. Effects of furosemide on allergic asthmatic responses in mice.
Wang S; Xiang YY; Ellis R; Wattie J; Feng M; Inman MD; Lu WY
Clin Exp Allergy; 2011 Oct; 41(10):1456-67. PubMed ID: 21729180
[TBL] [Abstract][Full Text] [Related]
16. Bee venom ameliorates ovalbumin induced allergic asthma via modulating CD4+CD25+ regulatory T cells in mice.
Choi MS; Park S; Choi T; Lee G; Haam KK; Hong MC; Min BI; Bae H
Cytokine; 2013 Jan; 61(1):256-65. PubMed ID: 23121887
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhaled ciclesonide on circulating T-helper type 1/T-helper type 2 cells in atopic asthmatics after allergen challenge.
Kawayama T; O'Byrne PM; Watson RM; Killian KJ; Duong M; Yoshida M; Gauvreau GM
Clin Exp Allergy; 2006 Nov; 36(11):1417-24. PubMed ID: 17083352
[TBL] [Abstract][Full Text] [Related]
18. Immune modulation of ovalbumin-induced lung injury in mice using β-glucosylceramide and a potential role of the liver.
Horani A; Shoseyov D; Doron S; Mruwat R; Amer J; Kerem E; Safadi R
Immunobiology; 2011 May; 216(5):548-57. PubMed ID: 21074892
[TBL] [Abstract][Full Text] [Related]
19. Contribution of regulatory T cells to alleviation of experimental allergic asthma after specific immunotherapy.
Maazi H; Shirinbak S; Willart M; Hammad HM; Cabanski M; Boon L; Ganesh V; Baru AM; Hansen G; Lambrecht BN; Sparwasser T; Nawijn MC; van Oosterhout AJ
Clin Exp Allergy; 2012 Oct; 42(10):1519-28. PubMed ID: 22994349
[TBL] [Abstract][Full Text] [Related]
20. Ciclesonide and the treatment of asthma.
Korenblat PE
Expert Opin Pharmacother; 2010 Feb; 11(3):463-79. PubMed ID: 20102309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
